First evidence of a possible association between gastric acid suppression during pregnancy and childhood asthma: a

E Dehlink1, E Yen, A M Leichtner

  • 1Division of Gastroenterology and Nutrition, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA.

Insights

Maternal use of acid-suppressive medications during pregnancy was linked to an increased risk of childhood asthma in offspring. This study provides evidence of a significant association between in utero drug exposure and asthma development.

Area of Science:

  • Pediatric Allergy and Immunology
  • Perinatal Pharmacology
  • Epidemiology

Background:

  • Emerging data in mice suggest prenatal acid suppression may predispose offspring to allergies.
  • Understanding the impact of maternal medication use on child health is crucial.

Purpose of the Study:

  • To investigate the association between in utero exposure to acid-suppressive drugs and the development of allergic diseases in children.
  • To determine if prenatal exposure to acid suppression increases the risk of childhood asthma.

Main Methods:

  • A population-based cohort study utilizing Swedish national healthcare registers.
  • Linking data on maternal medication use, birth outcomes, and childhood diagnoses/prescriptions for allergic diseases.
  • Statistical analysis using the Mantel-Haenszel procedure to assess associations.

Main Results:

  • Prenatal exposure to acid-suppressive medications was associated with an increased risk of childhood allergy (OR 1.43).
  • This association persisted regardless of drug type, timing, or maternal allergy history.
  • A significant increase in the odds of developing childhood asthma was observed (OR 1.51), but not other allergic diseases.

Conclusions:

  • This study presents the first evidence linking in utero exposure to acid-suppressive drugs with an elevated risk of childhood asthma.
  • Further research is warranted to elucidate the mechanisms behind this association and its clinical implications.
Abstract

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...